Form 4: Relay Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Filing Form 4
Donald A. Bergstrom, President of R&D at Relay Therapeutics, sold 765 shares of common stock to cover income tax withholding obligations upon the vesting of restricted stock units.
Summary
- On March 27, 2024, Donald A. Bergstrom, President of R&D at Relay Therapeutics, sold 765 shares of the company's common stock.
- The sale was executed at a price of $7.7 per share.
- This transaction was to cover income tax withholding obligations related to the vesting of 2,188 restricted stock units (RSUs) on March 26, 2024.
- Following the transaction, Bergstrom beneficially owns 530,113 shares of Relay Therapeutics, including 481,567 shares underlying RSUs.
Sentiment
Score: 5
Explanation: This is a routine transaction to cover tax obligations, so it's neutral in sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders (officers, directors, or those holding more than 10% of the company's shares) buy or sell the company's securities. This provides transparency to the market regarding insider transactions.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 03/26/2024 | Vesting of 2,188 shares of restricted stock units (RSUs). |
| 03/27/2024 | Sale of 765 shares of common stock by Donald A. Bergstrom. |
| 03/29/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.